Get the Stockscreener App
2.13
6.17%
-0.14
Eledon Pharmaceuticals Inc Stock (ELDN) Forecast
The Eledon Pharmaceuticals Inc (ELDN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.5182, representing a +18.23% increase from the current price of $2.13. The highest analyst price target is $3.1211, and the lowest is $1.9154.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELDN Price Target
Average 1.5669
(-26.44% Downside)
Is Eledon Pharmaceuticals Inc (ELDN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 23.86 | Buy |
| STOCH(9,6) | 17.64 | Buy |
| STOCHRSI(14) | 20.25 | Neutral |
| MACD(12,26) | -0.1827 | Sell |
| ADX(14) | 18.92 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -88.51 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.37
Sell
|
2.3483
Sell
|
| MA20 |
2.4963
Sell
|
2.4819
Sell
|
| MA50 |
2.9237
Sell
|
2.8165
Sell
|
| MA100 |
3.3231
Sell
|
3.0479
Sell
|
| MA200 |
3.0717
Sell
|
3.084
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ELDN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on ELDN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23.86 indicates that ELDN is oversold. This indicates that ELDN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 17.64 indicates that ELDN is oversold. This indicates that ELDN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.25 indicates that ELDN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.92 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -88.51 indicates that ELDN is still oversold but not to an extreme extent.
Long-term ELDN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eledon Pharmaceuticals Inc financial reports and earnings history, Eledon Pharmaceuticals Inc (ELDN) stock could reach $1.0298 by 2030, $5.5806 by 2040 and $10.90 by 2050. See the projected annual prices until 2050 of the Eledon Pharmaceuticals Inc stock below:
- Eledon Pharmaceuticals Inc (ELDN) is expected to reach an average price of $2.509 in 2035, with a high prediction of $2.5453 and a low estimate of $2.5821. This indicates an $17.79% rise from the last recorded price of $2.13.
- Eledon Pharmaceuticals Inc (ELDN) stock is projected to chart a bullish course in 2040, with an average price target of $5.6585, representing an $165.66% surge from its current level. The forecast ranges from a conservative $5.6779 to a sky-high $5.5806.
- Our analysts predict Eledon Pharmaceuticals Inc (ELDN) to jump 260.63% by 2045, soaring from $7.7977 to an average price of $7.6814, potentially reaching $7.6905. While $7.7977 is the low estimate, the potential upside is significant.
- Eledon Pharmaceuticals Inc (ELDN) stock is expected to climb by 2050, reaching an average of $10.13, a $375.48% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.90 and $10.93, respectively, highlighting the market's uncertainty.
Eledon Pharmaceuticals Inc Stock (ELDN) Year by Year Forecast
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2026
The predicted value for Eledon Pharmaceuticals Inc (ELDN) in 2026 is set at an average of $2.7021. Estimates vary from a peak of $4.4899 to a trough of $0.9143, indicating an +26.86% surge from the present price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.9827 | $1.9154 | $3.1211 | -6.92% |
| December, 2026 | $1.7458 | $0.9143 | $2.1785 | -18.04% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eledon Pharmaceuticals Inc (ELDN) is $1.1438, with a high forecast of $2.275 and a low forecast of $0.0127. This indicates an -46.30% decrease from the last price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.879 | $0.8041 | $2.275 | -58.73% |
| February, 2027 | $1.3421 | $0.5048 | $1.4621 | -36.99% |
| March, 2027 | $0.591 | $0.321 | $1.5579 | -72.25% |
| April, 2027 | $1.1742 | $0.1168 | $1.3584 | -44.87% |
| May, 2027 | $0.0731 | $0.0127 | $1.2028 | -96.57% |
| June, 2027 | $0.4563 | $0.0305 | $1.2163 | -78.58% |
| July, 2027 | $0.0206 | $0.2264 | $1.1086 | -99.03% |
| August, 2027 | $0.0183 | $0.0183 | $0.7383 | -99.14% |
| September, 2027 | $0.5615 | $0.0291 | $1.067 | -73.64% |
| October, 2027 | $0.8946 | $0.361 | $1.2872 | -58.00% |
| November, 2027 | $0.0737 | $0.0262 | $1.0904 | -96.54% |
| December, 2027 | $0.1733 | $0.2257 | $0.2543 | -91.86% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2028
In 2028, Eledon Pharmaceuticals Inc (ELDN) is projected to reach an average price of $0.6228, with a high projection of $1.1861 and a low estimate of $0.0596. This indicates an -70.76% fall from the last price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0444 | $0.0618 | $0.2882 | -97.91% |
| February, 2028 | $0.2513 | $0.2171 | $0.2629 | -88.20% |
| March, 2028 | $0.7819 | $0.0596 | $1.1861 | -63.29% |
| April, 2028 | $0.165 | $0.0851 | $0.9649 | -92.25% |
| May, 2028 | $0.2261 | $0.1677 | $0.1856 | -89.39% |
| June, 2028 | $0.00706 | $0.2444 | $0.2355 | -99.67% |
| July, 2028 | $0.104 | $0.0598 | $0.5402 | -95.12% |
| August, 2028 | $0.5309 | $0.4967 | $0.3067 | -75.08% |
| September, 2028 | $0.9877 | $0.8251 | $0.8535 | -53.63% |
| October, 2028 | $1.0398 | $1.032 | $0.9441 | -51.18% |
| November, 2028 | $0.7857 | $0.8957 | $0.9931 | -63.11% |
| December, 2028 | $1.0725 | $0.8899 | $0.9825 | -49.65% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2029
The 2029 price forecast for Eledon Pharmaceuticals Inc Stock (ELDN) is $0.6853 on average, with a high prediction of $1.3463 and a low estimate of $0.0242. This represents an -67.83% decrease from the previous price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6595 | $0.8582 | $0.8668 | -69.04% |
| February, 2029 | $0.9605 | $0.7578 | $0.9363 | -54.91% |
| March, 2029 | $0.9373 | $1.0873 | $1.0531 | -55.99% |
| April, 2029 | $0.4483 | $0.4242 | $0.6616 | -78.95% |
| May, 2029 | $0.4253 | $0.4211 | $0.3726 | -80.03% |
| June, 2029 | $0.3321 | $0.3321 | $0.3096 | -84.41% |
| July, 2029 | $0.0432 | $0.1232 | $0.3421 | -97.97% |
| August, 2029 | $0.0201 | $0.1701 | $0.3216 | -99.06% |
| September, 2029 | $0.9631 | $0.0242 | $1.2315 | -54.79% |
| October, 2029 | $0.702 | $0.2546 | $1.2979 | -67.04% |
| November, 2029 | $0.6951 | $0.2893 | $0.8451 | -67.36% |
| December, 2029 | $0.7541 | $0.3809 | $1.3463 | -64.60% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2030
Eledon Pharmaceuticals Inc Stock (ELDN) is expected to reach an average price of $2.0394 in 2030, with a high forecast of $3.6393 and a low forecast of $0.4395. This signifies an -4.25% decrease from the last price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.6972 | $0.4614 | $1.0298 | -67.27% |
| February, 2030 | $0.6903 | $0.4395 | $0.7403 | -67.59% |
| March, 2030 | $2.7435 | $0.6361 | $2.8535 | +28.80% |
| April, 2030 | $2.7824 | $1.8766 | $3.6393 | +30.63% |
| May, 2030 | $2.4955 | $2.0897 | $3.214 | +17.16% |
| June, 2030 | $2.1887 | $1.8487 | $3.1371 | +2.75% |
| July, 2030 | $2.4876 | $2.1655 | $3.151 | +16.79% |
| August, 2030 | $1.7307 | $1.5207 | $2.6734 | -18.74% |
| September, 2030 | $1.2397 | $0.8539 | $1.8865 | -41.80% |
| October, 2030 | $1.1628 | $1.1228 | $1.8154 | -45.41% |
| November, 2030 | $1.3759 | $1.0987 | $1.5609 | -35.40% |
| December, 2030 | $1.4049 | $0.9133 | $1.4849 | -34.04% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):